FibroBiologics Inc
FBLG
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.43M
Close$
$1.11
4% upside
Current Fair Value
4% upsideUndervalued by 4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.43 Million |
|---|---|
| Enterprise Value | $3.18 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.4 |
| Beta | 1.19 |
| Outstanding Shares | 2,233,026 |
Return
| Return on Equity | -718.46% |
|---|---|
| Return on Assets | -314.58% |
| Return on Invested Capital | -447.21% |
Valuation & Multiples
| P/E Ratio | -0.14 |
|---|---|
| PEG | -20.25 |
| Price to Sales | - |
| Price to Book Ratio | 1.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.7 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.82
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.85%▼ 0.04% |
|---|---|
| Total Invested | $290,211▼ 70.80% |
| Investors Holding | 16▼ 28.00% |
ESG Score
No data